A new analysis of the SURPASS-3 trial sheds light on how tirzepatide, a medication for type 2 diabetes, influences muscle composition—specifically muscle volume and fat infiltration. Led by Professor Naveed
Continue readingTirzepatide’s Effects on Muscle Composition Overtime
Emerging research suggests that GLP-1 drugs—commonly used for managing diabetes and obesity—may also support brain health. Semaglutide-based drugs like Ozempic and Wegovy, as well as tirzepatide (Zepbound), may provide neuroprotective benefits that go beyond their well-known effects on weight loss. …
Continue readingGLP-1 Drugs like Ozempic May Protect Brain Health.
The rise of “Ozempic babies” has garnered attention nationwide, spotlighting the unexpected link between GLP-1 medications, weight loss, and enhanced fertility. Originally developed for diabetes management, GLP-1 receptor agonists (GLP-1 RAs) like Ozempic, Wegovy, Mounjaro, and Zepbound have also shown surprising benefits, including significant weight loss, improved cardiovascular and kidney health, and now, a possible boost in fertility. …
Mounjaro (tirzepatide) and Ozempic (semaglutide) – What’s the difference? …
Continue readingMounjaro (tirzepatide) and Ozempic (semaglutide) – What’s the difference?